Trial intelligence / Profile preview

Tiotropium in Cystic Fibrosis

NCT00737100Phase 2Completed

Sponsor
Boehringer Ingelheim
Start
Sep 2008
Primary completion
Apr 2010
Modality
Small Molecules
Countries
11
01

Overview

A Phase 2 trial of tiotropium in cystic fibrosis (CF), sponsored by Boehringer Ingelheim. Started Sep 2008; status: completed.

02

Drugs

tiotropium
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT00737100.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00737100.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call